Studying the Impact of Golgi Glypican73 Serving as a Candidate Biomarker in Early Diagnosis for Hepatocellular Carcinoma Among Saudi Patients

Asian Pacific Journal of Cancer Prevention
doi 10.31557/apjcp.2019.20.1.215
Full Text
Abstract

Available in full text

Date
Authors
Publisher

EpiSmart Science Vector Ltd

Related search

Plasma Osteopontin as a Novel Diagnostic Biomarker for Early Detection of Hepatocellular Carcinoma.

International Journal of Advanced Research
2017English

Exosomal miR-665 as a Novel Minimally Invasive Biomarker for Hepatocellular Carcinoma Diagnosis and Prognosis

Oncotarget
Oncology
2017English

Serum Golgi Protein 73 in Patients With Hepatocellular Carcinoma.

International Journal of Advanced Research
2017English

Identification of CELSR2 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Screening and Early Diagnosis of Hepatocellular Carcinoma

ACTUAL INFECTOLOGY
2018English

Circular RNA Hsa_circ_0078602 May Have Potential as a Prognostic Biomarker for Patients With Hepatocellular Carcinoma

Oncology Letters
Cancer ResearchOncology
2018English

CD24 as a Novel Predictive Biomarker in Patients With Hepatocellular Carcinoma: Friend or Foe?

Journal of Investigative Surgery
Surgery
2018English

Modularity of the Metabolic Gene Network as a Prognostic Biomarker for Hepatocellular Carcinoma

Oncotarget
Oncology
2018English

Serum Long Noncoding RNA LRB1 as a Potential Biomarker for Predicting the Diagnosis and Prognosis of Human Hepatocellular Carcinoma

Oncology Letters
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy